Skip links


Technology Is Creating A Marketing Identity Crisis: Here’s How CMOs Can Define Their Role

Summary: In his article published on Forbes, Jeff Fleischman, CMO at Altimetrik, discusses the evolving role of Chief Marketing Officers (CMOs) in the face of technological advancements, data proliferation, and changing market dynamics. Fleischman highlights the challenges CMOs face in defining their role and emphasizes the need for CMOs to lead their teams through a proactive transformation. He suggests several strategies for CMOs to embrace:

  1. Become a technology leader: CMOs should lead the implementation of marketing technology, capitalizing on the data and technology ecosystem independent of the main IT organization. This requires embracing new tools and talent while aligning tech adoption with business goals.
  2. Become data-driven: Customer centricity begins with understanding customer desires and needs. CMOs should leverage the growing availability of data sources, including internal, external, and third-party data, to gain insights into customer behavior, preferences, and trends.
  3. Focus on the customer experience: Marketing should seamlessly integrate into the customer journey, working alongside sales and customer service. Targeted marketing and behavioral marketing can engage potential customers effectively while avoiding oversaturation.
  4. Connect marketing to corporate strategy: All marketing decisions and activities should align with the company’s overarching goals. CMOs should establish clear ROI measurements and key performance indicators (KPIs) to gauge the success of marketing initiatives.

Fleischman underscores that CMOs must lead their teams through digital transformation, utilizing data and technology to enhance marketing decisions and contribute greater value to the business.

Read the full article >


Latest News

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes